Malaria Vaccine 'could be widespread by 2015'
Wednesday, October 09, 2013
Researchers reported at a malaria conference in Durban, South Africa, that the jab continues to protect a substantial proportion of babies and young children 18 months after vaccination. The mosquito-borne disease kills around 660,000 people every year, most of them children in Sub-Saharan Africa.
British pharmaceutical firm GlaxoSmithKline (GSK), which makes the vaccine, said it would apply for a licence from the European Medicines Agency next year.
The recent disclosure by the IEC that 2,513 registrations have been turned down due to various irregularities should prompt all Batswana to meticulously review the voters' rolls and address concerns about rejected registrations.The disparities flagged by the IEC are troubling and emphasise the significance of rigorous voter registration processes.Out of the rejected registrations, 29 individuals were disqualified due to non-existent Omang...